Genentech. Has a futuristic ring to it, doesn’t it? Yet, for more than 35 years, Genentech, Inc., has been known as one of the world’s leading biotechnology companies. Focused primarily on cardiology and oncology, it keeps the door open to “opportunistic” projects where the company has the potential to fill a void in other significant areas of medicine.
Research & Insights
